CHESTERFIELD, Mo.—EyePromise, a company that provides scientifically supported eye vitamins to support eye health, has announced that it has been acquired by PRN Physician Recommended Nutriceuticals, which partners with ophthalmologists and optometrists to provide patients with evidence-based nutriceuticals to support their long-term ocular health. According to the announcement, the acquisition is effective immediately. The newly combined company will allow both organizations to provide a greater value and service to its partners, the companies said, from practices to patients to suppliers and more.

With complementary areas of expertise, PRN and EyePromise said they believe that the combination will create a one-stop-shop for its partners.

“EyePromise has always focused on sound science, premium quality and customer success for both patients and doctors," Andreas Wolf, president of EyePromise, told VMAIL. "PRN shares these values, so in working together, we will be able to accelerate our mission to preserve and enhance eye health globally. That’s the future I’m excited to see.”

“We’re excited to bring PRN, the anterior eye experts, and EyePromise, the posterior eye experts, together," Andrew Loucks, chief executive officer of Acumen Health Holdings, the parent company of PRN, told VMAIL. "These are the makings of a true eye health leader obsessed with providing unmatched, comprehensive solutions to the industry. We are thrilled to create that next-level partnership with practitioners across the U.S. and abroad, ultimately helping more patients enhance their eye health.”

PRN also recently acquired the Avenova eyecare business from NovaBay Pharmaceuticals, Inc., as reported by VMAIL.